Aspin: Neurosurgical Aspirin Intervention Prognostic Study; perioperative continuation versus discontinuation of aspirin in spinal surgery, a randomized controlled, noninferiority trial.
Recruiting
- Conditions
- 10014523Bleedingstroke1008220610041543
- Registration Number
- NL-OMON54741
- Lead Sponsor
- Haaglanden Medisch Centrum
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Not specified
- Target Recruitment
- 554
Inclusion Criteria
Elective spinal surgery
Pre-operative use of aniplatelet drugs
Pre-operative use of aspirin
Exclusion Criteria
Spinal oncology
Staged surgeries lasting more than one day
Patients with a pre-existing coagulopathy
Patients using antithrombotic drugs or other platelet aggregation inhibitors
than aspirin
Patients with absolute contraindication for discontinuing aspirin (e.g.
coronary stenting within 1 year)
Patients aged under 18
Emergency surgical procedures
Incompetence to decide, i.e. in case of severe cognitive impairment or
psychiatric illness.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method <p>See study objectives. </p><br>
- Secondary Outcome Measures
Name Time Method <p>See study objectives. </p><br>